<DOC>
	<DOCNO>NCT01978262</DOCNO>
	<brief_summary>The purpose pilot research project look effect inactivate influenza vaccine ( seasonal flu shot ) early sign immune germ-fighting response know cytokine signal molecule . The investigator also want see time vaccine administration effect woman 's reproductive hormone . The investigator hypothesis influenza vaccine give right ovulation may change hormone level usually see ovulation . Thi</brief_summary>
	<brief_title>Immune Hormone Response Influenza Vaccine</brief_title>
	<detailed_description>This study open-label , longitudinal study healthy young woman reproductive age , hormonal contraception receive seasonal inactivated influenza vaccine ( IIV ) . The woman follow one menstrual cycle measure luteinizing hormone surge , estradiol , progesterone , vaccinate seasonal inactivated influenza vaccine prior ovulation second month . At investigator 's discretion , active circulation influenza virus Baltimore , investigator vaccinate first menstrual cycle ( prior ovulation ) follow second menstrual cycle comparison . After vaccination , follow cytokine chemokine response well change concentration steroid hormone . This study evaluate effect IIV inflammatory cytokine hormonal response ovulation . Each woman 13 visit addition screen visit , follow 2 complete menstrual cycle .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Women 1839 year age good health . Good general health result review medical history and/or clinical testing time screen . Available duration trial . Willingness participate study evidence sign informed consent document . Willing abstinent use nonhormonal method contraception duration study . History normal menstrual cycle ( 2635 day length ) least 3 month . Willingness refrain routine vaccination ( except administer study ) duration study . Use contraceptive pill , patch , injection hormonal therapy precede 3 month ( 6 month DepoProvera ) A history hypersensitivity , include anaphylaxis component IIV egg . Previous receipt season license influenza vaccine . Pregnancy determine positive urine serum human choriogonadotropin ( βhCG ) test point study precede 3 month . Currently lactate breastfeed . Fewer 3 normal menstrual cycle since conclusion last pregnancy last use hormonal birth control . A history autoimmune disease , chronic medical condition consider clinically significant investigator . History HIV , Hepatitis C active Hepatitis B . Known immunodeficiency syndrome . History GuillainBarré syndrome . Use chronic oral intravenous administration ( ≥14 day ) immunosuppressive dos steroid , i.e. , prednisone &gt; 10 mg per day , immunosuppressant immunemodifying drug within 30 day start study . ( Use topical , nasal inhaled steroid permit ) Receipt live vaccine within 4 week kill vaccine within 2 week prior study start study . Receipt blood bloodderived product ( include immunoglobulin ) within 6 month prior study vaccination . Receipt another investigational vaccine drug within 30 day prior study start , study . Ongoing , daily use analgesic antiinflammatory medication , include nonsteroidal antiinflammatories . Occasional use , use associate menstrual period acceptable .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>influenza vaccine</keyword>
	<keyword>cytokine</keyword>
	<keyword>hormone</keyword>
	<keyword>progesterone</keyword>
</DOC>